⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL55047 | 1.00 | — | — | |
| SCHEMBL791249 | 1.00 | — | — | |
| SCHEMBL1041254 | 1.00 | — | — | |
| SCHEMBL2107037 | 1.00 | — | — | |
| SCHEMBL2932270 | 1.00 | — | — | |
| SCHEMBL5549445 | 1.00 | — | — | |
| SCHEMBL3518225 | 1.00 | — | — | |
| SCHEMBL2687210 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL2340361 | 0.97 | — | — | |
| SCHEMBL28118146 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037354-B2 | Cyclic pantetheine derivatives and uses thereof | VECTIVBIO COMET AG (CH) | 2024-07-16 | — | — | US | disclosed |
| US-20230218578-A1 | BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2023-07-13 | — | — | US | disclosed |
| US-20230107216-A1 | PANTETHEINE DERIVATIVES AND USES THEREOF | VECTIVBIO COMET AG, F/K/A COMET THERAPEUTICS, INC. (CH) | 2023-04-06 | — | — | US | disclosed |
| US-20230072313-A1 | CYCLIC PANTETHEINE DERIVATIVES AND USES THEREOF | VECTIVBIO COMET AG, F/K/A COMET THERAPEUTICS, INC. (CH) | 2023-03-09 | — | — | US | disclosed |
| EP-3887381-A2 | CYCLIC PANTETHEINE DERIVATIVES AND USES THEREOF | Comet Therapeutics, Inc. (US) | 2021-10-06 | — | — | EP | disclosed |
| WO-2020113213-A2 | CYCLIC PANTETHEINE DERIVATIVES AND USES THEREOF | COMET THERAPEUTICS, INC. (US) | 2020-06-04 | — | — | WO | disclosed |
| US-9777301-B2 | Method for producing optically active amine compounds by deracemization | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2017-10-03 | — | — | US | disclosed |
| US-20160289715-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE AMINE COMPOUNDS BY DERACEMIZATION | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2016-10-06 | — | — | US | disclosed |
| US-20160168204-A1 | METHOD FOR PURIFYING OLIGOSACCHARIDE PEPTIDE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-06-16 | — | — | US | disclosed |
| US-20160017015-A1 | GLYCO-MODIFIED ATRIAL NATRIURETIC PEPTIDE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-01-21 | — | — | US | disclosed |
| EP-1315732-B1 | RADICICOL AND MONOCILLIN AND THEIR ANALOGUES AND USES THEREOF | SLOAN KETTERING INST CANCER (US) | 2006-06-07 | — | — | EP | disclosed |
| WO-2006009789-A2 | ARYL-SUBSTITUTED PIPERAZINE DERIVATIVES | NEUROGEN CORPORATION (US) | 2006-01-26 | — | — | WO | disclosed |
| US-20060009456-A1 | Aryl-substituted piperazine derivatives | NEUROGEN CORPORATION | 2006-01-12 | — | — | US | disclosed |
| US-20020091151-A1 | Novel macrocycles and uses thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2002-07-11 | — | — | US | disclosed |
| EP-1077970-A1 | 11-ARYL-BENZO(B)NAPHTHO(2,3-D)FURANS AND 11-ARYL-BENZO(B)NAPHTHO(2,3-D)THIOPHENES USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA | AMERICAN HOME PRODUCTS CORPORATION (US) | 2001-02-28 | — | — | EP | disclosed |
| US-6110962-A | FOR TREATING INSULIN RESISTANCE, TYPE II DIABETES, HYPERGLYCEMIA, MODULATING INSULIN LEVELS IN MAMMALS | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-08-29 | — | — | US | disclosed |
| WO-1999058521-A1 | 11-ARYL-BENZO[B]NAPHTHO[2,3-D]FURANS AND 11-ARYL-BENZO[B]NAPHTHO[2,3-D]THIOPHENES USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-11-18 | — | — | WO | disclosed |
| US-5145957-A | Carbapenicillin intermediates | MERCK & CO., INC. (US) | 1992-09-08 | — | — | US | disclosed |
| EP-0333268-A1 | Process for synthesis of a chiral 3-beta hydrogen (3R) 4-aroyloxy azetidinone | MERCK & CO. INC. (US) | 1989-09-20 | — | — | EP | disclosed |
| US-4778883-A | 3-(CHFCH3)-azetidinone intermediates | SANRAKU INCORPORATED (JP) | 1988-10-18 | — | — | US | disclosed |